Cyndeo Wealth Partners LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Cyndeo Wealth Partners LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 28,842 shares of the healthcare conglomerate's stock after buying an additional 2,957 shares during the period. UnitedHealth Group makes up approximately 1.2% of Cyndeo Wealth Partners LLC's holdings, making the stock its 13th largest holding. Cyndeo Wealth Partners LLC's holdings in UnitedHealth Group were worth $16,864,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group in the third quarter worth $27,000. Macroview Investment Management LLC boosted its position in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Delos Wealth Advisors LLC lifted its stake in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate's stock worth $30,000 after purchasing an additional 53 shares during the period. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at $31,000. Finally, Global Wealth Strategies & Associates boosted its stake in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after buying an additional 32 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Argus raised their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a "buy" rating in a research note on Wednesday, July 17th. Cantor Fitzgerald upped their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an "overweight" rating in a research report on Wednesday. UBS Group lowered their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday. Barclays raised their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an "overweight" rating in a report on Wednesday, July 17th. Finally, Jefferies Financial Group raised UnitedHealth Group from a "hold" rating to a "buy" rating and lifted their target price for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $615.58.

UnitedHealth Group Stock Up 0.6 %

NYSE UNH traded up $3.58 on Friday, hitting $569.61. 3,687,045 shares of the company were exchanged, compared to its average volume of 3,498,377. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The company has a market cap of $525.99 billion, a PE ratio of 37.11, a PEG ratio of 1.67 and a beta of 0.58. The stock has a fifty day moving average of $584.42 and a 200-day moving average of $534.68.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts' consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the business earned $6.56 EPS. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. The ex-dividend date was Monday, September 16th. UnitedHealth Group's dividend payout ratio is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.